OUTCOME OF CHILDREN WITH NON HIGH RISK NEUROBLASTOMA TREATED IN NORTHERN EGYPT

被引：0
|
作者：
Alsheikh, H. [1 ]
Mashali, N. [2 ]
Badawy, H. [3 ]
Abd-Elkarem, A. [4 ]
Fadel, S. [1 ]
机构：
[1] Fac Med, Pediat Oncol Unit, Alexandria, Egypt
[2] Fac Med, Dept Pathol, Alexandria, Egypt
[3] Fac Med, Dept Urol, Alexandria, Egypt
[4] Fac Med, Diagnost & Intervent Radiol, Alexandria, Egypt
来源：
PEDIATRIC BLOOD & CANCER | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-359
引用
收藏
页码：S327 / S327
页数：1
相关论文
共 50 条
  • [21] Pharmacologic Management of High-Risk Neuroblastoma in Children
    Ganeshan, Veena R.
    Schor, Nina F.
    PEDIATRIC DRUGS, 2011, 13 (04) : 245 - 255
  • [22] Pharmacologic Management of High-Risk Neuroblastoma in Children
    Veena R. Ganeshan
    Nina F. Schor
    Pediatric Drugs, 2011, 13 : 245 - 255
  • [23] Short Stature Among High-Risk Neuroblastoma Survivors Treated with Non-TBI Regimen
    Tsumura, Y.
    Kiyotani, C.
    Shioda, Y.
    Osumi, T.
    Kato, M.
    Tomizawa, D.
    Terashima, K.
    Hishiki, T.
    Fuji, H.
    Horikawa, R.
    Matsumoto, K.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S282 - S283
  • [24] Healthcare utilization disparities among children with high-risk neuroblastoma treated on Children's Oncology Group clinical trials
    Shoag, Jamie
    Li, Yimei
    Getz, Kelly D.
    Huang, Yuan-Shung
    Hall, Matt
    Naranjo, Arlene
    Richardson, Troy
    Desai, Ami V.
    Umaretiya, Puja J.
    Aziz-Bose, Rahela
    Kelly, Colleen A.
    Zheng, Daniel J.
    Newman, Haley
    Zahler, Stacey
    Aplenc, Richard
    Bagatell, Rochelle
    Bona, Kira
    PEDIATRIC BLOOD & CANCER, 2024, 71 (10)
  • [25] Outcome analysis of non-high-risk neuroblastoma patients enrolled on Children's Oncology Group trials P9641 and A3961
    Meany, Holly Jane
    Attiyeh, Edward F.
    Naranjo, Arlene
    Twist, Clare
    London, Wendy B.
    Villablanca, Judith
    Schmidt, Mary Lou
    Baker, Dave
    Strother, Douglas R.
    Shimada, Hiroyuki
    Matthay, Katherine K.
    Cohn, Susan Lerner
    Maris, John M.
    Park, Julie R.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [26] Long-term outcomes in children with high-risk neuroblastoma treated with autologous stem cell transplantation
    T N Trahair
    M R Vowels
    K Johnston
    R J Cohn
    S J Russell
    K A Neville
    S Carroll
    G M Marshall
    Bone Marrow Transplantation, 2007, 40 : 741 - 746
  • [27] Late effects in children treated with intensive multimodal therapy for high-risk neuroblastoma: High incidence of endocrine and growth problems
    L E Cohen
    J H Gordon
    E Y Popovsky
    S Gunawardene
    E Duffey-Lind
    L E Lehmann
    L R Diller
    Bone Marrow Transplantation, 2014, 49 : 502 - 508
  • [28] Long-term outcomes in children with high-risk neuroblastoma treated with autologous stem cell transplantation
    Trahair, T. N.
    Vowels, M. R.
    Johnston, K.
    Cohn, R. J.
    Russell, S. J.
    Neville, K. A.
    Carroll, S.
    Marshall, G. M.
    BONE MARROW TRANSPLANTATION, 2007, 40 (08) : 741 - 746
  • [29] 'ULTRA-HIGH-RISK' NEUROBLASTOMA SUBGROUP: A TOOL TO PREDICT SURVIVAL IN CHILDREN WITH NEWLY DIAGNOSED HIGH-RISK NEUROBLASTOMA
    Yadgarov, Mikhail
    Matveev, Nikolai
    Kailash, Chaurasiya
    Shamanskaya, Tatyana
    Kachanov, Denis
    Likar, Yury
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S221 - S221
  • [30] Late effects in children treated with intensive multimodal therapy for high-risk neuroblastoma: High incidence of endocrine and growth problems
    Cohen, L. E.
    Gordon, J. H.
    Popovsky, E. Y.
    Gunawardene, S.
    Duffey-Lind, E.
    Lehmann, L. E.
    Diller, L. R.
    BONE MARROW TRANSPLANTATION, 2014, 49 (04) : 502 - 508
12345